The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization.

por Kieffer, B L, Befort, K, Gaveriaux-Ruff, C, Hirth, C G
Publicado 1992

The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization.

por Kieffer, B L, Befort, K, Gavériaux-Ruff, C, Hirth, C G
Publicado 1994

In vivo properties of KNT-127, a novel δ opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice

por Nozaki, C, Nagase, H, Nemoto, T, Matifas, A, Kieffer, B L, Gaveriaux-Ruff, C
Publicado en Br J Pharmacol (2014)

Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence

por Lalanne, L., Ayranci, G., Filliol, D., Gavériaux-Ruff, C., Befort, K., Kieffer, B. L., Lutz, P-E
Publicado en Addict Biol (2016)

Mu opioid receptors in the medial habenula contribute to naloxone aversion

por Boulos, L. J., Ben Hamida, S., Bailly, J., Maitra, M., Ehrlich, A. T., Gavériaux-Ruff, C., Darcq, E., Kieffer, B. L.
Publicado en Neuropsychopharmacology (2019)

kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system.

por Simonin, F, Gavériaux-Ruff, C, Befort, K, Matthes, H, Lannes, B, Micheletti, G, Mattéi, M G, Charron, G, Bloch, B, Kieffer, B
Publicado 1995

Atrial G protein-activated K+ channel: expression cloning and molecular properties.

por Dascal, N, Schreibmayer, W, Lim, N F, Wang, W, Chavkin, C, DiMagno, L, Labarca, C, Kieffer, B L, Gaveriaux-Ruff, C, Trollinger, D
Publicado 1993